Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP
出版年份 2023 全文链接
标题
Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP
作者
关键词
-
出版物
European Journal of Pharmacology
Volume -, Issue -, Pages 176157
出版商
Elsevier BV
发表日期
2023-11-07
DOI
10.1016/j.ejphar.2023.176157
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Montelukast as a potential treatment for COVID-19
- (2023) Matthew W. McCarthy EXPERT OPINION ON PHARMACOTHERAPY
- Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development—a narrative review
- (2023) Mariacarmela Santarpia et al. Translational Lung Cancer Research
- Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models
- (2023) Yumeng Wang et al. Cell Death Discovery
- The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
- (2022) Albert K. Kwan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants
- (2022) Marco H. Hofmann et al. Cancer Discovery
- Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
- (2022) Marc Cucurull et al. Frontiers in Oncology
- KRAS: A Druggable Target in Colon Cancer Patients
- (2022) Francesca Negri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sotorasib: First approved KRAS mutation inhibitor for the treatment of non-small cell lung cancer
- (2022) Surya K. De CURRENT MEDICINAL CHEMISTRY
- Drugging KRAS: current perspectives and state-of-art review
- (2022) Kaushal Parikh et al. Journal of Hematology & Oncology
- Targeting KRAS in PDAC: A New Way to Cure It?
- (2022) Qianyu He et al. Cancers
- Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
- (2022) Cátia F. Marques et al. Pharmaceuticals
- KRAS inhibitors: going noncovalent
- (2022) Matthias Drosten et al. Molecular Oncology
- KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
- (2022) Sahar F. Bannoura et al. Frontiers in Oncology
- Mechanisms of Resistance to KRASG12C Inhibitors
- (2021) Victoria Dunnett-Kane et al. Cancers
- KRAS mutation in pancreatic cancer
- (2021) Ji Luo SEMINARS IN ONCOLOGY
- Targeting KRAS in pancreatic cancer: new drugs on the horizon
- (2021) Sahar F. Bannoura et al. CANCER AND METASTASIS REVIEWS
- Sotorasib: First Approval
- (2021) Hannah A. Blair DRUGS
- Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
- (2021) Kenta Kachi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
- (2021) Xiaolun Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
- (2021) Yuta Adachi et al. Cancers
- KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
- (2020) Alex Friedlaender et al. CANCER TREATMENT REVIEWS
- Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets
- (2020) Huiqin He et al. JOURNAL OF INVESTIGATIVE MEDICINE
- KRAS: From undruggable to a druggable Cancer Target
- (2020) Dipesh Uprety et al. CANCER TREATMENT REVIEWS
- Structures of N-terminally processed KRAS provide insight into the role of N-acetylation
- (2019) Srisathiyanarayanan Dharmaiah et al. Scientific Reports
- Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma
- (2019) Carla Mottini et al. CANCER RESEARCH
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
- (2019) G. Aaron Hobbs et al. Cancer Discovery
- Artificial intelligence and big data facilitated targeted drug discovery
- (2019) Benquan Liu et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
- (2018) Caixia Tang et al. CANCER BIOLOGY & THERAPY
- Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells
- (2017) Ming-Ju Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started